Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
POINT Biopharma Global (PNT)
NASDAQ:PNT
RESEARCH TOOLSreports
Holding PNT?
Track your performance easily
PNT Stock Chart & Stats
Day’s Range$12.49 - $12.51
52-Week Range― - ―
Previous Close$12.48
Volume3.29M
Average Volume (3M)N/A
Market Cap
$1.33B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$12.50Price Target Upside0.00%
Rating ConsensusHold
Number of Analyst Covering8
POINT Biopharma Global News
PremiumPress Releases
Lilly Completes Acquisition of POINT Biopharma
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
29.21% Other Institutional Investors
70.79% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PNT FAQ
What was POINT Biopharma Global’s price range in the past 12 months?
Currently, no data Available
What is POINT Biopharma Global’s market cap?
Currently, no data Available
When is POINT Biopharma Global’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were POINT Biopharma Global’s earnings last quarter?
Currently, no data Available
Is POINT Biopharma Global overvalued?
According to Wall Street analysts POINT Biopharma Global’s price is currently same.
Does POINT Biopharma Global pay dividends?
POINT Biopharma Global does not currently pay dividends.
What is POINT Biopharma Global’s EPS estimate?
POINT Biopharma Global’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does POINT Biopharma Global have?
Currently, no data Available
What happened to POINT Biopharma Global’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of POINT Biopharma Global?
Among the largest hedge funds holding POINT Biopharma Global’s share is Baker Bros Advisors LP. It holds POINT Biopharma Global’s shares valued at 2M.
---
POINT Biopharma Global Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$12.50 (0.00% )
$12.50 (0.00% )
Blogger Sentiment
Bullish
PNT Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 973.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $213.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
75.07%
12-Months-Change
Fundamentals
Return on Equity
26.33%
Trailing 12-Months
Asset Growth
46.68%
Trailing 12-Months
Company Description
POINT Biopharma Global
Therapeutics Acquisition Corp is a blank check company.
---
PNT Stock 12 Month Forecast
Average Price Target
$12.50
▲(0.00% Upside)
Technical Analysis
Best Analysts Covering PNT
1 Year
1 Year Success Rate
3/4 ratings generated profit
1 Year Average Return
+50.68%
reiterated a buy rating a year ago
Copying Zhiqiang Shu's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +50.68% per trade.
---